PDCA循环在慢性阻塞性肺疾病患者吸入剂使用中的应用价值

Application value of PDCA circulation in inhalant use in patients with chronic obstructive pulmonary disease

目的分析PDCA循环在提高慢性阻塞性肺疾病患者吸入剂使用正确率中的应用价值。方法选取2021年1月15日至3月7日于崇左市人民医院呼吸内科接受治疗的48例慢性阻塞性肺疾病患者为对照组,未实施PDCA循环模式。选取2021年5月31日至7月11日于崇左市人民医院呼吸内科接受治疗的46例慢性阻塞性肺疾病患者为观察组,实施PDCA循环模式。比较两组患者的吸入剂使用正确率、肺功能、依从性及生存质量。结果观察组患者的吸入剂正确使用率高于对照组,差异有统计学意义(P<0.05)。入院时,两组患者的肺活量(FVC)、第一秒用力呼气量(FEV_(1))及第一秒用力呼气量占所有呼气量的比例(FEV_(1)/FVC),Morisky用药依从性量表(MMAS-8)评分以及生存质量评分比较,差异无统计学意义(P>0.05)。干预后,两组患者的FVC、FEV_(1)、FEV_(1)/FVC、MMAS-8评分以及生存质量评分均高于入院时,且观察组患者的FVC、FEV_(1)、FEV_(1)/FVC、MMAS-8评分以及生存质量评分高于对照组,差异有统计学意义(P<0.05)。结论PDCA循环可提高慢性阻塞性肺疾病患者的吸入剂使用正确率,促进肺功能改善,提高依从性,促进生存质量提高,适合在临床实施和开展,但是在实际的临床运用当中,还是应当结合患者的实际情况进行综合性的分析,从而帮助患者更好地进行恢复和康复。

Objective To analyze the application value of PDCA cycle in improving the correct rate of inhalant use in patients with chronic obstructive pulmonary disease.Methods Forty-eight patients with chronic obstructive pulmonary disease who received treatment in the Department of Respiratory Medicine,Chongzuo People's Hospital from January 15 to March 7,2021 were selected as the control group,without PDCA circulation mode.Forty-six patients with chronic obstructive pulmonary disease who received treatment in the Department of Respiratory Medicine,Chongzuo People's Hospital from May 31 to July 11,2021 were selected as the observation group,and PDCA cycle mode was implemented.The accuracy of inhalant use,lung function,compliance and quality of life were compared between the two groups.Results The correct use rate of inhalants in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).At the time of admission,there were no statistically significant differences between the two groups in forced vital capacity(FVC),forced expiratory volume in first second(FEV_(1)),the proportion of forced expiratory volume in first second to total forced vital capacity(FEV_(1)/FVC),Morisky medication adherence scale(MMAS-8)scores and quality of life scores(P>0.05).After intervention,the FVC,FEV_(1),FEV_(1)/FVC,MMAS-8 and quality of life scores of patients in the two groups were higher than those at admission,and the FVC,FEV_(1),FEV_(1)/FVC,MMAS-8 and quality of life scores of patients in the observation group were higher than those in the control group,with statistically significant differences(P<0.05).Conclusion PDCA circulation can improve the correct rate of inhaler use in patients with chronic obstructive pulmonary disease,promote the improvement of lung function,improve compliance,and improve the quality of life,which is suitable for clinical implementation and development.However,in the actual clinical application,comprehensive analysis should be carried out in combination with the actual situation of patients,so as to help patients better recover and recover.